Ngenla 24 mg/1.2mL
somatrogon-ghla · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
Ngenla is a injection, solution containing somatrogon-ghla at 24 mg/1.2mL, taken subcutaneous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- Ngenla
- Generic Name
- somatrogon-ghla
- NDC Code (Product)
0069-0505- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 24 mg/1.2mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761184
- Marketing Start
- 07/31/2023
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Ngenla used for?
Ngenla contains somatrogon-ghla. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Ngenla a controlled substance?
Ngenla is not classified as a controlled substance by the DEA.
What is the generic name for Ngenla?
The generic name for Ngenla is somatrogon-ghla. There are no other listed brand versions of somatrogon-ghla.
What is the NDC code for Ngenla 24 mg/1.2mL?
The NDC (National Drug Code) for Ngenla 24 mg/1.2mL is 0069-0505, listed by Pfizer Laboratories Div Pfizer Inc.
Other Ngenla Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)